Effects of hydroxypropyl-β-cyclodextrin on the chemical stability and the aqueous solubility of thalidomide enantiomers

Pharmazie

Volumn 63, Issue 7, 2008, Pages 511-513

  Alvarez, Covadonga ^a   Calero, J ^a   Menendez J C ^a   Torrado, S ^a   Torrado, J J ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; EXCIPIENT; SODIUM CHLORIDE; THALIDOMIDE;

AQUEOUS SOLUTION; ARTICLE; CONCENTRATION RESPONSE; DRUG DEGRADATION; DRUG SOLUBILITY; DRUG STABILITY; ENANTIOMER; ENANTIOSELECTIVITY; ORAL DRUG ADMINISTRATION;

BETA-CYCLODEXTRINS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; EXCIPIENTS; IMMUNOSUPPRESSIVE AGENTS; SOLUBILITY; SPECTROPHOTOMETRY, ULTRAVIOLET; STEREOISOMERISM; THALIDOMIDE;

EID: 48249102234     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2008.8507     Document Type: Article

References (13)

1. 1-acid glycoprotein chiral stationary phase. Chromatographia 52: 455-458.
2. Eriksson T, Björkman S, Roth B, Höglund P (2000) Intravenous formulations of the enantiomers of thalidomide: pharmacokinetic and initial pharmacodynamic characterization in man. J Pharm Pharmacol 52: 807-817.
3. Frömming H-H, Szejtli (1994) J. Cyclodextrins in Pharmacy. The Netherlands: Kluwer Academic Press.
4. Groll AH, Wood L, Roden M, Mickiene D, Chiou CC, Townley E, Dad L, Piscitelli SC, Walsh TJ (2002) Safety, pharmacokinetics, and pharmacodynamics of cyclodextrin itraconazole in pediatric patients with oropharyngeal candidiasis. Antimicrob Agents Chemother 46: 2554-2563.
5. Hess S, Akermann MA, Wnendt S, Zwingenberger K, Eger K (2001) Synthesis and inmunological activity of water-soluble thalidomide prodrugs. Bioorg Med Chem 9: 1279-1291.
6. Higuchi T, Connors KA (1965) Phase solubility techniques. Adv Anal Chem Instrum 4: 117-212.
7. Höglund P, Eriksson T, Björkman S (1998) A double-blind study of the sedative effects of the thalidomide enantiomers in humans. J Pharm Biopharm 26: 363-383.
8. Jibaly RM, Moallem H, Fikrig SM, Rabinowitz SS (1998) Steroid-resistant idiopathic esophageal ulcer in a child with AIDS. J Pediatr Gastroenterol Nutr. 27: 97101.
9. Keravich DP, Daniels CE (1999) Challenges of thalidomide distribution in a hospital setting. Am J Health Syst Pharm 56: 1721-1725.
10. Krenn M, Gamcsik MP, Vogelsang GB (1992) Improvements in solubility and stability of thalidomide upon complexation with hydroxypropyl-β- cyclodextrin. J Pharm Sci 81: 685-689.
11. Scheiderman E, Stalcup AM (2000) Cyclodextrins: a versatile tool in separation science. J Chromatogr Biomed Sci Appl 745: 83-102.
12. Soler RA, Migliorati C, van Waes H, Nadal D (1996a) Thalidomide treatment of mucosal ulcerations in HIV infection. Arch Dis Child. 74: 64-65.
13. Soler RA, Howard M, Brink NS, Gibb D, Tedder RS, Nadal D (1996b) Regression of ATDS-related Kaposi's sarcoma during therapy with thalidomide. Clin Infect Dis 23: 501-503.